Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Effect of Lemborexant-Based Sleep Medication Formulary on Benzodiazepine Reduction and Clinical Outcomes: A Single-Center Retrospective Study.
Neuropsychopharmacol Rep
September 2025
Department of Pharmaceutical Sciences, School of Pharmacy at Narita International University of Health and Welfare, Narita, Chiba, Japan.
Benzodiazepine and non-benzodiazepine hypnotics (Z-drugs) are known risk factors for adverse events, including delirium and falls. Although formularies are intended to promote appropriate prescribing, few comprehensive studies have assessed their clinical impact in the context of sleep medications. This study aimed to evaluate changes in hypnotic prescribing patterns and associated clinical outcomes following the implementation of a sleep medication formulary.
View Article and Find Full Text PDFCritical Care Antineoplastic Infusions: Safety and Practice Essentials.
AACN Adv Crit Care
September 2025
Michele L. Weber is Clinical Nurse Specialist, Medical Intensive Care Unit, The James Cancer Hospital and Solove Research Institute, Columbus, Ohio.
Oncology care is rapidly evolving due to the continual emergence of new treatment. Despite the shift toward outpatient cancer care, many patients still need inpatient hospitalization for antineoplastic infusion therapies because of a variety of factors. Acute and critical care nurses may be responsible for administering complex intravenous therapies to treat cancer.
View Article and Find Full Text PDFSecondary Infusion Underdelivery: Risks and Rewards of Common Workarounds.
AACN Adv Crit Care
September 2025
Nathaniel M. Sims is Research Faculty, Department of Anesthesia, Mass General Brigham (MGB). Associate Professor, Harvard Medical School. Newbower/Eitan MGH Endowed Chair in Biomedical Technology Innovation. Physician Advisor, MGB Biomedical Engineering, Boston, Massachusetts.
Secondary medication delivery using large-volume smart pumps offers important workflow and safety benefits. However, the widely used linear peristaltic large-volume smart pumps rely on sufficient head-height differential for accurate secondary infusion, leading to underdelivery risks. This article outlines common clinician workarounds used to mitigate these risks, including delivering secondary medications via primary mode, programming excess volume to be infused, clamping primary lines, and using short-set primary delivery.
View Article and Find Full Text PDFOptimizing Patient Safety: Intravenous Smart Pump Usability in Acute and Critical Care.
AACN Adv Crit Care
September 2025
Dian Baker is Professor Emeritus, School of Nursing, California State University, Sacramento, California.
Large-volume intravenous (IV) smart pumps are used in acute and critical care to deliver IV fluids and medications with safety-enhancing features such as dose error reduction systems. Although these technologies offer improvements over manual administration, IV smart pumps are associated with high rates of medication errors, programming challenges, and usability issues. Alarm fatigue, interface complexity, and workarounds are common, with studies showing high error rates.
View Article and Find Full Text PDFObjective: A high percentage of medication errors are preventable; therefore, institutions are constantly striving to try to reduce them. When errors occur with high-risk medications, the possibility of causing serious harm to the patient increases, making the implementation of safe practices essential to try to avoid them. The main objective of the study was to establish in a second-level hospital, and especially in Pediatrics, practices for the safe management of these drugs at all stages of their handling.
View Article and Find Full Text PDF